Vedolizumab是一種整聯蛋白受體拮抗劑，是一種在中國倉鼠卵巢細胞中產生的人源化IgG1單克隆抗體，可與人α4β7整聯蛋白結合。Vedolizumab的分子量約為147千道爾頓。 Vedolizumab生物類似藥-研究級該產品同種型對照：Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 緩沖液：ICH3001-100ml，nICH3002-100ml，nICH3003-100ml， 濃度：1.0 - 5.0 mg/ml 純度：>95% by SDS-PAGE and HPLC 內毒素：≤ 1.0 EU/mg as determined by the LAL method 制劑：Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
